Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor

for
Metastatic Cancer
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT00107367

Phase 1, Phase 2, Recruiting

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 18

Code: NCT00491946

Recruiting

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

for
Solid Tumor
Location: Rochester MN, San Antonio TX, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT02963168

Phase 1, Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

for
Obesity, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 13 - 30

Code: NCT04453072

Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT00992303

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Effectiveness of Central Oncology Navigation and the Use of an ORN

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06618274

Recruiting

Promoting Physical Activity In After-School Programs for Urban Adolescents

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Montclair NJ
Sponsor: Montclair State University

Sex: All

Age: 11 - 14

Code: NCT00301158

Recruiting

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

for
Tumor, Solid, Pancreatic Cancer, Melanoma
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03454035

Phase 1, Recruiting

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Toronto, Orlando FL,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase 1, Recruiting

Young Adult Infusion Space Experience Satisfaction Survey

for
Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 39

Code: NCT05720546

Recruiting

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

for
Head and Neck Cancer, Relapse, Recurrent, Refractory Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06096038

Phase 1, Recruiting

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

for
Metastatic Malignant Solid Neoplasm
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06606990

Phase 1, Recruiting

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

for
Advanced Solid Tumor
Location: Fairfax VA, Cleveland OH, Dallas TX, San Antonio TX,
Sponsor: 1ST Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05761223

Phase 1, Phase 2, Recruiting

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

for
Pediatric Cancer, Cancer, Cancer Metastatic, Survivorship
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 1 - 39

Code: NCT05096923

Recruiting

Exercise and Relaxation Intervention for Young Adult Cancer Survivors

for
Cancer
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 39

Code: NCT00801008

Recruiting

The Effects of Case Management in a Medicaid Managed Care Plan

for
Neoplasms, Heart Diseases, Adrenal Cortex Diseases
Location: Brooklyn NY
Sponsor: Metropolitan Jewish Health System

Sex: All

Age: 18+

Code: NCT00385879

Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, NSCLC Adenocarcinoma, Cholangiocarcinoma,
Location: Boston MA, New York NY, Grand Rapids MI, San Antonio TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06723236

Phase 1, Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

for
Malignant Neoplasm
Location: Jersey City NJ, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 1+

Code: NCT02688517

Recruiting

Study of ACR-2316 in Specific Advanced Solid Tumors

for
Specific Advanced Solid Tumors
Location: Boston MA, Providence RI, The Bronx NY, Fairfax VA,
Sponsor: Acrivon Therapeutics

Sex: All

Age: 18+

Code: NCT06667141

Phase 1, Phase 2, Recruiting

A Phase I Open-label Study for Subjects With Advanced Malignancies

for
Advanced Solid Malignancies
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT04136834

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial